Chipotle Testing Critical Levels After Grand Jury Inquiry

Steve Kanaval |

Shares of Chipotle Mexican grill (CMG) are trading lower again this morning as this beleaguered stock tests important support levels which will determine the future direction of shares. Looking back at the price appreciation since 2009 CMG has been one of the markets best performers. Shares were trading $50 in 2009 and rose to $750 in this 7 year run. Today retesting the $438 level is a critical retest in the eyes of all market watchers. Several store closings, weaker revenue numbers and the recent Grand Jury inquiry tests the nerve of any portfolio manager seeking value in this restaurant sector darling. Many got paid being long Chipotle, now the trade will sort itself out trying to determine if this is a value at the current support level ($438) or if leadership will change hands.

Chipotle says it has been served with a federal grand jury subpoena as part of a criminal investigation tied to a norovirus outbreak this summer at one of its restaurants in California. The investigation is being conducted by the U.S. Attorney's Office for the Central District of California in conjunction with the Food and Drug Administration, the company said in a filing with the Securities and Exchange Commission Wednesday.

Chipotle Mexican Grill says the subpoena requires it to produce a "broad range" of documents. The Denver company has been reeling since an E. coli outbreak linked to its restaurants, which was followed up by a separate norovirus outbreak in Boston. Chipotle says it expects sales for the fourth quarter to be down 14.6 percent.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
CMG Chipotle Mexican Grill Inc. 364.69 -1.68 -0.46 801,516


Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets


Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…


A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.